Search research articles
Contact Us
Filters
Showing results (41-50 of 372) with videos related to
Page
of 38
Sort By:
Leukemia & Lymphoma
|
August 10, 2017
Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors
Emilie Cayssials, Florence Tartarin, Joëlle Guilhot, et al.
Leukemia Research
|
April 28, 2009
SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia
Stéphanie Poulain, Marjan Ertault, Xavier Leleu, et al.
Cancer Immunology, Immunotherapy : CII
|
September 4, 2010
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
Céline Berthon, Virginie Driss, Jizhong Liu, et al.
Cancer Treatment and Research
|
October 4, 2016
Treatment of Newly Diagnosed Elderly Multiple Myeloma
Guillemette Fouquet, Francesca Gay, Eileen Boyle, et al.
European Journal of Haematology
|
June 25, 2008
Proteomics analysis in post-transplant lymphoproliferative disorders
Yazan Alsayed, Xavier Leleu, Alexey Leontovich, et al.
Experimental Hematology
|
December 2, 2009
A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients
Klaudia Kuranda, Céline Berthon, Caroline Dupont, et al.
Expert Review of Hematology
|
October 1, 2014
Pomalidomide for multiple myeloma
Guillemette Fouquet, Claire Bories, Stéphanie Guidez, et al.
Haematologica
|
September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
Philippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2011
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia
Xavier Leleu, Wanling Xie, Meghan Bagshaw, et al.
European Journal of Haematology
|
May 9, 2024
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study
Murielle Roussel, Nathalie Texier, Virginie Nael, et al.
Page
of 38
Search research articles
Search
Showing results (41-50 of 372) with videos related to
Sort By:
Page
of 38
Leukemia & Lymphoma
|
August 10, 2017
Sustained molecular response in chronic myeloid leukemia deep responders treated with low dose tyrosine kinase inhibitors
Emilie Cayssials, Florence Tartarin, Joëlle Guilhot, et al.
Leukemia Research
|
April 28, 2009
SDF1/CXCL12 (-801GA) polymorphism is a prognostic factor after treatment initiation in Waldenstrom macroglobulinemia
Stéphanie Poulain, Marjan Ertault, Xavier Leleu, et al.
Cancer Immunology, Immunotherapy : CII
|
September 4, 2010
In acute myeloid leukemia, B7-H1 (PD-L1) protection of blasts from cytotoxic T cells is induced by TLR ligands and interferon-gamma and can be reversed using MEK inhibitors
Céline Berthon, Virginie Driss, Jizhong Liu, et al.
Cancer Treatment and Research
|
October 4, 2016
Treatment of Newly Diagnosed Elderly Multiple Myeloma
Guillemette Fouquet, Francesca Gay, Eileen Boyle, et al.
European Journal of Haematology
|
June 25, 2008
Proteomics analysis in post-transplant lymphoproliferative disorders
Yazan Alsayed, Xavier Leleu, Alexey Leontovich, et al.
Experimental Hematology
|
December 2, 2009
A subpopulation of malignant CD34+CD138+B7-H1+ plasma cells is present in multiple myeloma patients
Klaudia Kuranda, Céline Berthon, Caroline Dupont, et al.
Expert Review of Hematology
|
October 1, 2014
Pomalidomide for multiple myeloma
Guillemette Fouquet, Claire Bories, Stéphanie Guidez, et al.
Haematologica
|
September 5, 2008
Prospective comparison of subcutaneous versus intravenous administration of bortezomib in patients with multiple myeloma
Philippe Moreau, Valerie Coiteux, Cyrille Hulin, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 19, 2011
The role of serum immunoglobulin free light chain in response and progression in waldenstrom macroglobulinemia
Xavier Leleu, Wanling Xie, Meghan Bagshaw, et al.
European Journal of Haematology
|
May 9, 2024
Effectiveness and safety of belantamab mafodotin in patients with relapsed or refractory multiple myeloma in real-world setting: The ALFA study
Murielle Roussel, Nathalie Texier, Virginie Nael, et al.
Page
of 38